Skip to main content
Clinical Trials/DRKS00033431
DRKS00033431
Recruiting
Phase 4

Evaluation of the Usability and Pharmaeconomy of the MicroTech Insulin Pump System

MicroTech Medical (Hangzhou) Co. Ltd.0 sites120 target enrollmentJanuary 18, 2024

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Diabetes type 1 and 2
Sponsor
MicroTech Medical (Hangzhou) Co. Ltd.
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 18, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
MicroTech Medical (Hangzhou) Co. Ltd.

Eligibility Criteria

Inclusion Criteria

  • Patients on insulin pump treatment (CSII, 100 patients)
  • Patients on insulin treatment (20 patients, Germany only)
  • HbA1c \< 9\.0 %
  • Subjects who are able to complete informed consent form (by him\-/herself or by his/her guardian)

Exclusion Criteria

  • Hypoglycemia unawareness
  • Nursing mothers
  • Any reason for not being able to comply with the protocol.
  • Serious disease or illness

Outcomes

Primary Outcomes

Not specified

Similar Trials